99% Savings - Buy Just @1 Rs X
Vinglyn M 1000 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Vinglyn M 1000 Tablet (15) safe for pregnant women?
Vinglyn M may have some side effects during pregnancy. Pregnant women should discontinue the use of Vinglyn M, and talk to their doctor, if they notice any discomfort.
Is the use of Vinglyn M 1000 Tablet (15) safe during breastfeeding?
Vinglyn M is safe for breastfeeding women.
What is the effect of Vinglyn M 1000 Tablet (15) on the Kidneys?
There may be some adverse effects on kidney after taking Vinglyn M. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Vinglyn M 1000 Tablet (15) on the Liver?
Vinglyn M can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Vinglyn M 1000 Tablet (15) on the Heart?
Side effects of Vinglyn M on heart are unknown because research on this has not been conducted yet.
If you are suffering from any of the following diseases, you should not take Vinglyn M 1000 Tablet (15) unless your doctor advises you to do so -
Is this Vinglyn M 1000 Tablet (15) habit forming or addictive?
Vinglyn M 1000 Tablet (15) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Vinglyn M 1000 Tablet (15). So it is best to avoid driving.
Is it safe?
Yes, but take Vinglyn M 1000 Tablet (15) only as per medical advice.
Is it able to treat mental disorders?
No, Vinglyn M 1000 Tablet (15) is not used to treat mental disorders.
Interaction between Food and Vinglyn M 1000 Tablet (15)
There isn't any research available on the side effects of taking Vinglyn M 1000 Tablet (15) with food.
Interaction between Alcohol and Vinglyn M 1000 Tablet (15)
Information about the interaction of Vinglyn M 1000 Tablet (15) and alcohol is not currently available because this topic has not been researched yet.
No, you should not take alcohol with Vinglyn M, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Vinglyn M than if you're just taking Vinglyn M. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
Yes, Vinglyn M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Vinglyn M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Vinglyn M may need to be adjusted.
Vinglyn M works by decreasing the hepatic glucose production. It also works to lower blood sugar by increasing your sensitivity to insulin and decreasing the amount of glucose that is absorbed from the food you eat.
Vinglyn M can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
Vinglyn M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275